首页 > 最新文献

Annals of Saudi medicine最新文献

英文 中文
Diabetes mellitus and the risk of spontaneous bacterial peritonitis in patients with liver cirrhosis: a systematic review and meta-analysis. 糖尿病与肝硬化患者自发性细菌性腹膜炎的风险:系统回顾和荟萃分析。
Pub Date : 2024-07-01 Epub Date: 2024-08-01 DOI: 10.5144/0256-4947.2024.272
Raghad Alhajaji, Mayada Mohammad Samkari, Mona A Althobaiti, Bashaer Ruddah Al-Ahmadi, Alaa Mohammed Bugis, Amjad Mohammed Bugis, Fatimah Yaseen Sabbagh, Somaya A Althobaiti, Amro S Bukari, Safenaz Meshal Alqurashi, Hana Abdullah Mshrai, Omar Ahmed Abdelwahab

Background: Spontaneous bacterial peritonitis (SBP) represents a critical and potentially lethal condition that typically develops in individuals with liver cirrhosis. This meta-analysis aimed to assess diabetes mellitus (DM) as a risk factor for SBP in liver cirrhotic patients.

Methods: Following PRISMA guidelines, fifteen studies were included, for a total of 76 815 patients. The risk of bias was assessed using the Newcastle-Ottawa scale (NOS). We represented the results as risk ratios (RR) with the corresponding 95% confidence intervals (CI) using RevMan software. Additionally, we pooled the hazard ratios (HR) for developing SBP in patients with DM from the included studies.

Results: The meta-analysis shows a significantly increased risk of SBP in cirrhotic patients with DM (HR: 1.26; 95% CI [1.05-1.51], P=.01; HR: 1.70; 95% CI [1.32-2.18], P<.001).

Conclusions: The study signifies that DM is an independent risk factor for SBP, emphasizing the need for targeted preventive measures in this specific population.

背景:自发性细菌性腹膜炎(SBP自发性细菌性腹膜炎(SBP)是肝硬化患者常见的一种严重且可能致命的疾病。本荟萃分析旨在评估糖尿病(DM)作为肝硬化患者SBP风险因素的情况:按照PRISMA指南,共纳入15项研究,共计76815名患者。采用纽卡斯尔-渥太华量表(NOS)评估了偏倚风险。我们使用RevMan软件将结果显示为风险比(RR)及相应的95%置信区间(CI)。此外,我们还汇总了纳入研究的 DM 患者发生 SBP 的危险比 (HR):荟萃分析表明,肝硬化DM患者罹患SBP的风险显著增加(HR:1.26;95% CI [1.05-1.51],P=.01;HR:1.70;95% CI [1.32-2.18],PC结论:该研究表明,DM 是导致 SBP 的一个独立风险因素,强调了在这一特殊人群中采取有针对性的预防措施的必要性。
{"title":"Diabetes mellitus and the risk of spontaneous bacterial peritonitis in patients with liver cirrhosis: a systematic review and meta-analysis.","authors":"Raghad Alhajaji, Mayada Mohammad Samkari, Mona A Althobaiti, Bashaer Ruddah Al-Ahmadi, Alaa Mohammed Bugis, Amjad Mohammed Bugis, Fatimah Yaseen Sabbagh, Somaya A Althobaiti, Amro S Bukari, Safenaz Meshal Alqurashi, Hana Abdullah Mshrai, Omar Ahmed Abdelwahab","doi":"10.5144/0256-4947.2024.272","DOIUrl":"10.5144/0256-4947.2024.272","url":null,"abstract":"<p><strong>Background: </strong>Spontaneous bacterial peritonitis (SBP) represents a critical and potentially lethal condition that typically develops in individuals with liver cirrhosis. This meta-analysis aimed to assess diabetes mellitus (DM) as a risk factor for SBP in liver cirrhotic patients.</p><p><strong>Methods: </strong>Following PRISMA guidelines, fifteen studies were included, for a total of 76 815 patients. The risk of bias was assessed using the Newcastle-Ottawa scale (NOS). We represented the results as risk ratios (RR) with the corresponding 95% confidence intervals (CI) using RevMan software. Additionally, we pooled the hazard ratios (HR) for developing SBP in patients with DM from the included studies.</p><p><strong>Results: </strong>The meta-analysis shows a significantly increased risk of SBP in cirrhotic patients with DM (HR: 1.26; 95% CI [1.05-1.51], <i>P</i>=.01; HR: 1.70; 95% CI [1.32-2.18], <i>P</i><.001).</p><p><strong>Conclusions: </strong>The study signifies that DM is an independent risk factor for SBP, emphasizing the need for targeted preventive measures in this specific population.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 4","pages":"272-287"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appendiceal neoplasms in Saudi Arabia: prevalence and clinicopathological profile. 沙特阿拉伯的阑尾肿瘤:发病率和临床病理特征。
Pub Date : 2024-07-01 Epub Date: 2024-08-01 DOI: 10.5144/0256-4947.2024.255
Mohammed Nabil AlAli, Ahmad Zubaidi, Thamer A Bin Traiki, Khayal Alkhayal, Mohammed Sbaih, Saud Khalid Aldeghaither, Farah F Almugrin, Sulaiman Abdullah Alshammari, Mohammed Alswayyed, Maha Abdullah

Background: The appendix is a small organ with no particular known function. Primary appendiceal neoplasms (ANs) are rare. While the prevalence is increasing worldwide over the past two decades, no apparent increase in the prevalence of ANs has been reported in the Arabian Gulf States. Recently, a significant decline in the age at diagnosis of some types of ANs has been reported worldwide, with a female predominance.

Objectives: Evaluate the prevalence and clinicopathological characteristics of ANs within our institution in Saudi Arabia and compare them to limited existing studies from different regions as well as the Arabian Gulf States.

Design: Retrospective cohort.

Setting: Tertiary care center in Riyadh.

Patients and methods: All patients who underwent appendectomy and had the appendix submitted for histopathological evaluation between May 2015 and June 2020 were included to allow for a follow-up of 5 years or more at the time of data collection.

Main outcome measures: Demographics, clinical presentations, surgical interventions, histopathological findings, complications, and recurrence rates.

Sample size: 25 AN patients.

Results: Of 1110 patients, 25 had ANs (13 female and 12 male participants) with a mean (standard deviation) age of 54.6 (14.1) years. Only 40% presented with acute appendicitis, 64% had comorbidities, and less than 50% underwent laparoscopic appendectomy. Histopathologically, 72% were low-grade appendiceal mucinous neoplasms (LAMNs). Complications were minimal grades (Clavien-Dindo classification), with 80% experiencing none. The mean hospital stay was 9.96 days. Local recurrence occurred in 8% of cases, and distant metastasis was documented in one adenocarcinoma case. However, the 5-year overall and disease-free survival rates were 88% and 80%, respectively.

Conclusions: The incidence of ANs is increasing in Saudi Arabia with the higher prevalence of LAMNs. The pathological examination of the resected appendix played a pivotal role in the diagnosis of ANs.

Limitations: Data collected retrospectively, a single institution, and a small population.

背景:阑尾是一个没有特殊功能的小器官。原发性阑尾肿瘤(ANs)非常罕见。过去二十年来,阑尾肿瘤的发病率在全球范围内不断上升,但阿拉伯海湾国家的阑尾肿瘤发病率却没有明显上升。最近,全球有报告称,某些类型的肛门瘤的确诊年龄明显下降,且以女性居多:评估本院在沙特阿拉伯的 ANs 患病率和临床病理特征,并将其与来自不同地区和阿拉伯海湾国家的有限的现有研究进行比较:设计:回顾性队列:患者和方法:所有接受阑尾切除术的患者:纳入所有在 2015 年 5 月至 2020 年 6 月期间接受阑尾切除术并提交阑尾进行组织病理学评估的患者,以便在收集数据时进行 5 年或更长时间的随访:主要结果测量指标:人口统计学、临床表现、手术干预、组织病理学结果、并发症和复发率:结果:1110 名患者中,25 人患有阑尾炎(女性 13 人,男性 12 人),平均(标准差)年龄为 54.6(14.1)岁。只有 40% 的患者患有急性阑尾炎,64% 的患者有合并症,不到 50% 的患者接受了腹腔镜阑尾切除术。从组织病理学角度来看,72%为低级别阑尾粘液瘤(LAMN)。并发症等级极低(Clavien-Dindo分类),80%的患者无并发症。平均住院时间为 9.96 天。8%的病例出现局部复发,1例腺癌病例出现远处转移。然而,5年总生存率和无病生存率分别为88%和80%:结论:在沙特阿拉伯,AN的发病率正在上升,其中LAMN的发病率较高。切除阑尾的病理检查在阑尾炎的诊断中起着关键作用:局限性:数据为回顾性收集,研究机构单一,研究人群较少。
{"title":"Appendiceal neoplasms in Saudi Arabia: prevalence and clinicopathological profile.","authors":"Mohammed Nabil AlAli, Ahmad Zubaidi, Thamer A Bin Traiki, Khayal Alkhayal, Mohammed Sbaih, Saud Khalid Aldeghaither, Farah F Almugrin, Sulaiman Abdullah Alshammari, Mohammed Alswayyed, Maha Abdullah","doi":"10.5144/0256-4947.2024.255","DOIUrl":"10.5144/0256-4947.2024.255","url":null,"abstract":"<p><strong>Background: </strong>The appendix is a small organ with no particular known function. Primary appendiceal neoplasms (ANs) are rare. While the prevalence is increasing worldwide over the past two decades, no apparent increase in the prevalence of ANs has been reported in the Arabian Gulf States. Recently, a significant decline in the age at diagnosis of some types of ANs has been reported worldwide, with a female predominance.</p><p><strong>Objectives: </strong>Evaluate the prevalence and clinicopathological characteristics of ANs within our institution in Saudi Arabia and compare them to limited existing studies from different regions as well as the Arabian Gulf States.</p><p><strong>Design: </strong>Retrospective cohort.</p><p><strong>Setting: </strong>Tertiary care center in Riyadh.</p><p><strong>Patients and methods: </strong>All patients who underwent appendectomy and had the appendix submitted for histopathological evaluation between May 2015 and June 2020 were included to allow for a follow-up of 5 years or more at the time of data collection.</p><p><strong>Main outcome measures: </strong>Demographics, clinical presentations, surgical interventions, histopathological findings, complications, and recurrence rates.</p><p><strong>Sample size: </strong>25 AN patients.</p><p><strong>Results: </strong>Of 1110 patients, 25 had ANs (13 female and 12 male participants) with a mean (standard deviation) age of 54.6 (14.1) years. Only 40% presented with acute appendicitis, 64% had comorbidities, and less than 50% underwent laparoscopic appendectomy. Histopathologically, 72% were low-grade appendiceal mucinous neoplasms (LAMNs). Complications were minimal grades (Clavien-Dindo classification), with 80% experiencing none. The mean hospital stay was 9.96 days. Local recurrence occurred in 8% of cases, and distant metastasis was documented in one adenocarcinoma case. However, the 5-year overall and disease-free survival rates were 88% and 80%, respectively.</p><p><strong>Conclusions: </strong>The incidence of ANs is increasing in Saudi Arabia with the higher prevalence of LAMNs. The pathological examination of the resected appendix played a pivotal role in the diagnosis of ANs.</p><p><strong>Limitations: </strong>Data collected retrospectively, a single institution, and a small population.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 4","pages":"255-263"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of discordance between femoral and lumbar bone mineral density among older adults in a community-based setting. 社区老年人股骨和腰椎骨矿物质密度不一致的普遍性。
Pub Date : 2024-07-01 Epub Date: 2024-08-01 DOI: 10.5144/0256-4947.2024.249
Muath A Alkhunizan, Nouf AlMasoud, Majd Munia Abdulmowla, Zoha Khalid, Mohammed Alshaker, Yaser Abdullah Alendijani

Background: T-score measurement via dual-energy X-ray absorptiometry (DXA) is the gold standard for assessing and classifying the bone mineral density status of patients as normal, osteopenic, or osteoporotic according to the World Health Organization criteria. However, the diagnostic accuracy may be affected by the skeletal site selected for DXA.

Objectives: Estimate the prevalence of femoral and lumbar BMD discordance in a community-based setting in Riyadh, Saudi Arabia.

Design: Cross-sectional.

Setting: Polyclinics at a tertiary care center.

Patients and methods: This study included all patients aged ≥60 years who visited the Department of Family Medicine and underwent DXA screening between 2016 and 2022.

Main outcome measures: Discordance was defined as a difference in BMD status between two skeletal sites. Minor discordance occurs when adjacent sites have different diagnoses; i.e., one site exhibits osteoporosis and the other exhibits osteopenia. In contrast, major discordance occurs when one site exhibits osteoporosis and the other exhibits normal BMD.

Sample size: 1429 older adults.

Results: The study patients had a median age of 66 years (60-99, minimum-maximum). The prevalence of discordance was 41.6%, with major discordance present in 2.2% of patients and minor discordance in 39.4%. The distribution of discordance did not differ significantly among the sociodemographic factors.

Conclusion: Discordance is prevalent among the Saudi geriatric population. During the analysis of DXA results, physicians should account for discordance when diagnosing and ruling out osteoporosis in high-risk patients.

Limitations: All factors influencing discordance were not explored thoroughly; this study mainly focused on older adults. Furthermore, diverse age groups need to be investigated for a more comprehensive understanding of the analyzed factors.

背景:根据世界卫生组织的标准,通过双能 X 射线吸收测量法(DXA)测量 T 值是评估患者骨矿密度状况并将其分为正常、骨质疏松或骨质疏松的金标准。然而,诊断的准确性可能会受到 DXA 所选骨骼部位的影响:评估沙特阿拉伯利雅得社区中股骨和腰椎 BMD 不一致的发生率:设计:横断面:背景:一家三级医疗中心的综合诊所:本研究纳入了2016年至2022年期间在全科医学科就诊并接受DXA筛查的所有年龄≥60岁的患者:不一致定义为两个骨骼部位之间 BMD 状态的差异。当相邻部位的诊断结果不同时,即一个部位显示骨质疏松症,另一个部位显示骨质疏松症时,就会出现轻度不一致。相反,当一个部位显示骨质疏松症,而另一个部位显示 BMD 正常时,就会出现严重不一致:研究患者的中位年龄为 66 岁(60-99 岁,最小-最大值)。不一致的发生率为 41.6%,其中 2.2% 的患者存在严重不一致,39.4% 的患者存在轻微不一致。不协调的分布在不同的社会人口因素中没有明显差异:结论:不一致性在沙特老年人群中普遍存在。在分析 DXA 结果时,医生在诊断和排除高危患者的骨质疏松症时应考虑到不一致性:局限性:未深入探讨影响不一致的所有因素;本研究主要关注老年人。此外,为了更全面地了解所分析的因素,还需要对不同年龄段的人群进行调查。
{"title":"Prevalence of discordance between femoral and lumbar bone mineral density among older adults in a community-based setting.","authors":"Muath A Alkhunizan, Nouf AlMasoud, Majd Munia Abdulmowla, Zoha Khalid, Mohammed Alshaker, Yaser Abdullah Alendijani","doi":"10.5144/0256-4947.2024.249","DOIUrl":"10.5144/0256-4947.2024.249","url":null,"abstract":"<p><strong>Background: </strong>T-score measurement via dual-energy X-ray absorptiometry (DXA) is the gold standard for assessing and classifying the bone mineral density status of patients as normal, osteopenic, or osteoporotic according to the World Health Organization criteria. However, the diagnostic accuracy may be affected by the skeletal site selected for DXA.</p><p><strong>Objectives: </strong>Estimate the prevalence of femoral and lumbar BMD discordance in a community-based setting in Riyadh, Saudi Arabia.</p><p><strong>Design: </strong>Cross-sectional.</p><p><strong>Setting: </strong>Polyclinics at a tertiary care center.</p><p><strong>Patients and methods: </strong>This study included all patients aged ≥60 years who visited the Department of Family Medicine and underwent DXA screening between 2016 and 2022.</p><p><strong>Main outcome measures: </strong>Discordance was defined as a difference in BMD status between two skeletal sites. Minor discordance occurs when adjacent sites have different diagnoses; i.e., one site exhibits osteoporosis and the other exhibits osteopenia. In contrast, major discordance occurs when one site exhibits osteoporosis and the other exhibits normal BMD.</p><p><strong>Sample size: </strong>1429 older adults.</p><p><strong>Results: </strong>The study patients had a median age of 66 years (60-99, minimum-maximum). The prevalence of discordance was 41.6%, with major discordance present in 2.2% of patients and minor discordance in 39.4%. The distribution of discordance did not differ significantly among the sociodemographic factors.</p><p><strong>Conclusion: </strong>Discordance is prevalent among the Saudi geriatric population. During the analysis of DXA results, physicians should account for discordance when diagnosing and ruling out osteoporosis in high-risk patients.</p><p><strong>Limitations: </strong>All factors influencing discordance were not explored thoroughly; this study mainly focused on older adults. Furthermore, diverse age groups need to be investigated for a more comprehensive understanding of the analyzed factors.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 4","pages":"249-254"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of corticosteroid administration for acute respiratory distress syndrome in adults based on meta-analyses and trial sequential analysis. 基于荟萃分析和试验序列分析的成人急性呼吸窘迫综合征皮质类固醇治疗临床结果。
Pub Date : 2024-05-01 Epub Date: 2024-06-06 DOI: 10.5144/0256-4947.2024.167
Di Wu, Yue Li, Shao-Hua Dong, Yue Gao

Background: Acute respiratory distress syndrome (ARDS), which results in lung injury as a consequence of sepsis and septic shock, is associated with severe systemic inflammation and is responsible for a high worldwide mortality rate.

Objective: Investigate whether corticosteroids could benefit clinical outcomes in adult with ARDS.

Methods: A comprehensive search of electronic databases Ovid MEDLINE, Ovid EMbase, and Cochrane Library from their inception to 7 May 2023 was conducted to identify studies that met the eligibility criteria, including only randomized controlled trials. The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the methods of trial sequential analysis.

Main outcome measures: Mortality rates, including including the 14-, 28-, 45-, and 60-day mortality, hospital mortality, and intensive care unit (ICU) mortality.

Sample size: 17 studies with 2508 patients.

Results: Data relating to mortality at 14, 28, 45, and 60 days were not significantly different when treatments with corticosteroids and placebo were compared. In terms of hospital and ICU mortality, the mortality of those who had received corticosteroids was significantly lower than that of those who had not. ARDS patients who received assisted ventilation benefited from corticosteroid therapy, as revealed by the significant difference in outcome days between those who received assisted ventilation and those who did not. Corticosteroid had significantly more days free from mechanical ventilation, ICU-free days, and MODS-free days during the first 28 days, but not more organ support-free days up to day 28.

Conclusion: Although corticosteroid therapy did not reduce mortality rates at different observation periods, it significantly reduced hospital and ICU mortality. Administering corticosteroids to ARDS patients significantly decreased the days of assisted ventilation and time cost consumption. This study confirmed that long-term use of low-dose glucocorticoids may have a positive effect on early ARDS.

Limitation: Risk of bias due to the differences in patient characteristics.

背景:急性呼吸窘迫综合征(ARDS)是脓毒症和脓毒性休克导致肺损伤的结果,与严重的全身炎症有关,是全球高死亡率的原因之一:研究皮质类固醇是否能改善成人 ARDS 患者的临床预后:对电子数据库 Ovid MEDLINE、Ovid EMbase 和 Cochrane Library 从开始到 2023 年 5 月 7 日进行了全面检索,以确定符合资格标准的研究,其中仅包括随机对照试验。研究按照系统综述和元分析首选报告项目(PRISMA)指南和试验顺序分析方法进行:死亡率,包括14天、28天、45天和60天死亡率、住院死亡率和重症监护室(ICU)死亡率:结果:与皮质类固醇和安慰剂相比,14、28、45和60天的死亡率数据没有明显差异。就住院和重症监护室死亡率而言,接受过皮质类固醇治疗的患者死亡率明显低于未接受过治疗的患者。接受辅助通气治疗的 ARDS 患者可从皮质类固醇治疗中获益,接受辅助通气治疗与未接受辅助通气治疗的患者在治疗天数上有明显差异。在最初的28天内,皮质类固醇治疗患者的无机械通气天数、无重症监护室天数和无MODS天数均明显增加,但直到第28天,无器官支持天数却没有增加:结论:虽然皮质类固醇治疗并不能降低不同观察期的死亡率,但却能显著降低住院和重症监护室死亡率。给 ARDS 患者使用皮质类固醇能明显减少辅助通气天数和时间成本消耗。这项研究证实,长期使用小剂量糖皮质激素可能对早期ARDS有积极作用:局限性:由于患者特征的差异,存在偏倚风险。
{"title":"Clinical outcomes of corticosteroid administration for acute respiratory distress syndrome in adults based on meta-analyses and trial sequential analysis.","authors":"Di Wu, Yue Li, Shao-Hua Dong, Yue Gao","doi":"10.5144/0256-4947.2024.167","DOIUrl":"10.5144/0256-4947.2024.167","url":null,"abstract":"<p><strong>Background: </strong>Acute respiratory distress syndrome (ARDS), which results in lung injury as a consequence of sepsis and septic shock, is associated with severe systemic inflammation and is responsible for a high worldwide mortality rate.</p><p><strong>Objective: </strong>Investigate whether corticosteroids could benefit clinical outcomes in adult with ARDS.</p><p><strong>Methods: </strong>A comprehensive search of electronic databases Ovid MEDLINE, Ovid EMbase, and Cochrane Library from their inception to 7 May 2023 was conducted to identify studies that met the eligibility criteria, including only randomized controlled trials. The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the methods of trial sequential analysis.</p><p><strong>Main outcome measures: </strong>Mortality rates, including including the 14-, 28-, 45-, and 60-day mortality, hospital mortality, and intensive care unit (ICU) mortality.</p><p><strong>Sample size: </strong>17 studies with 2508 patients.</p><p><strong>Results: </strong>Data relating to mortality at 14, 28, 45, and 60 days were not significantly different when treatments with corticosteroids and placebo were compared. In terms of hospital and ICU mortality, the mortality of those who had received corticosteroids was significantly lower than that of those who had not. ARDS patients who received assisted ventilation benefited from corticosteroid therapy, as revealed by the significant difference in outcome days between those who received assisted ventilation and those who did not. Corticosteroid had significantly more days free from mechanical ventilation, ICU-free days, and MODS-free days during the first 28 days, but not more organ support-free days up to day 28.</p><p><strong>Conclusion: </strong>Although corticosteroid therapy did not reduce mortality rates at different observation periods, it significantly reduced hospital and ICU mortality. Administering corticosteroids to ARDS patients significantly decreased the days of assisted ventilation and time cost consumption. This study confirmed that long-term use of low-dose glucocorticoids may have a positive effect on early ARDS.</p><p><strong>Limitation: </strong>Risk of bias due to the differences in patient characteristics.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"167-182"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiographic and functional results of Ilizarov fixation in the management of nonunion of tibia and femur fractures: a retrospective case series. Ilizarov固定术治疗胫骨和股骨骨折不愈合的影像学和功能效果:回顾性病例系列。
Pub Date : 2024-05-01 Epub Date: 2024-06-06 DOI: 10.5144/0256-4947.2024.146
Mohamed A A Ibrahim, Khalid M Alhomayani, Usama Gaber, Hashem A Bukhary, Samir A Nematallah, Mostafa M Elgahel

Background: Femoral and tibial fractures may result in delayed union and nonunion, posing significant challenges in orthopedic practice. The Ilizarov technique has emerged as a promising solution for managing these complex cases.

Objectives: Evaluate the radiographic and functional results of Ilizarov fixation in the treatment of nonunion of tibia and femur fractures.

Design: Retrospective.

Settings: Hospitals affiliated with a university hospital.

Patients and methods: Patient demographics, fracture characteristics, and treatment details were analyzed for the period from October 2015 to September 2022 in patients who were treated for nonunion of the tibia and femur using the Ilizarov fixator. Clinical and radiological assessments were performed using the Association for the Study and Application of Methods of Ilizarov (ASAMI) criteria. The study focused on assessing the average duration for union and frame removal, bone results, successful union rates, and functional results using the ASAMI criteria, obtaining data from the existing medical records, spanning various medical facilities treating nonunion fractures.

Sample size: 126 patients.

Results: The average duration for union and frame removal was 8 months, with excellent bone results observed in 60.32% of cases. Out of 126 patients, 118 achieved successful union, while there were 2 failure cases necessitating amputation (1.52%). Functional results revealed excellent outcomes in 39.68% of cases. Complications included pin tract infections, ankle and knee stiffness, and limb shortening. External fixation duration and infection eradication were consistent with previous research, emphasizing the technique's effectiveness.

Conclusions: The Ilizarov technique proved highly effective in managing nonunion tibia and femur fractures, offering favorable outcomes in terms of union, infection control, pain relief, and functional recovery. While excellent bone outcomes do not guarantee optimal function, this method remains a reliable approach for complex cases.

Limitations: Potential biases inherent in retrospective analyses and the need for further randomized controlled trials to comprehensively compare treatment modalities.

背景:股骨和胫骨骨折可能导致延迟愈合和不愈合,给骨科实践带来了巨大挑战。Ilizarov技术已成为处理这些复杂病例的一种有前途的解决方案:评估Ilizarov固定治疗胫骨和股骨骨折不愈合的影像学和功能效果:设计:回顾性:患者和方法:患者的人口统计学特征、骨折情况和功能:分析了2015年10月至2022年9月期间使用Ilizarov固定器治疗胫骨和股骨骨折不愈合患者的人口统计学特征、骨折特征和治疗细节。临床和放射学评估采用伊利扎洛夫方法研究与应用协会(ASAMI)标准进行。研究的重点是使用 ASAMI 标准评估骨结合和骨架移除的平均持续时间、骨结果、成功结合率和功能结果,并从现有的医疗记录中获取数据,这些数据跨越了治疗骨折不愈合的各个医疗机构:结果:骨折愈合和移除骨架的平均时间为 8 个月,60.32% 的病例骨质效果极佳。在 126 例患者中,118 例成功接合,2 例失败,需要截肢(1.52%)。功能结果显示,39.68%的病例效果极佳。并发症包括针道感染、踝关节和膝关节僵硬以及肢体缩短。外固定持续时间和感染根除情况与之前的研究一致,强调了该技术的有效性:事实证明,Ilizarov 技术在治疗胫骨和股骨非愈合骨折方面非常有效,在愈合、感染控制、疼痛缓解和功能恢复方面都取得了良好的效果。虽然良好的骨愈合效果并不能保证最佳的功能,但对于复杂病例来说,这种方法仍然是一种可靠的方法:局限性:回顾性分析可能存在固有偏差,需要进一步开展随机对照试验,以全面比较各种治疗方法。
{"title":"Radiographic and functional results of Ilizarov fixation in the management of nonunion of tibia and femur fractures: a retrospective case series.","authors":"Mohamed A A Ibrahim, Khalid M Alhomayani, Usama Gaber, Hashem A Bukhary, Samir A Nematallah, Mostafa M Elgahel","doi":"10.5144/0256-4947.2024.146","DOIUrl":"10.5144/0256-4947.2024.146","url":null,"abstract":"<p><strong>Background: </strong>Femoral and tibial fractures may result in delayed union and nonunion, posing significant challenges in orthopedic practice. The Ilizarov technique has emerged as a promising solution for managing these complex cases.</p><p><strong>Objectives: </strong>Evaluate the radiographic and functional results of Ilizarov fixation in the treatment of nonunion of tibia and femur fractures.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Settings: </strong>Hospitals affiliated with a university hospital.</p><p><strong>Patients and methods: </strong>Patient demographics, fracture characteristics, and treatment details were analyzed for the period from October 2015 to September 2022 in patients who were treated for nonunion of the tibia and femur using the Ilizarov fixator. Clinical and radiological assessments were performed using the Association for the Study and Application of Methods of Ilizarov (ASAMI) criteria. The study focused on assessing the average duration for union and frame removal, bone results, successful union rates, and functional results using the ASAMI criteria, obtaining data from the existing medical records, spanning various medical facilities treating nonunion fractures.</p><p><strong>Sample size: </strong>126 patients.</p><p><strong>Results: </strong>The average duration for union and frame removal was 8 months, with excellent bone results observed in 60.32% of cases. Out of 126 patients, 118 achieved successful union, while there were 2 failure cases necessitating amputation (1.52%). Functional results revealed excellent outcomes in 39.68% of cases. Complications included pin tract infections, ankle and knee stiffness, and limb shortening. External fixation duration and infection eradication were consistent with previous research, emphasizing the technique's effectiveness.</p><p><strong>Conclusions: </strong>The Ilizarov technique proved highly effective in managing nonunion tibia and femur fractures, offering favorable outcomes in terms of union, infection control, pain relief, and functional recovery. While excellent bone outcomes do not guarantee optimal function, this method remains a reliable approach for complex cases.</p><p><strong>Limitations: </strong>Potential biases inherent in retrospective analyses and the need for further randomized controlled trials to comprehensively compare treatment modalities.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"146-152"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of body mass index in anastomotic leakage after curative treatment for rectal cancer. 体重指数在直肠癌根治术后吻合口漏中的作用。
Pub Date : 2024-05-01 Epub Date: 2024-06-06 DOI: 10.5144/0256-4947.2024.135
Reem Alharbi, Osama Almosallam, Sara Albastaki, Asim Almughamsi, Nasser Alsanea

Background: Anastomotic leakage (AL) represents a severe complication after rectal surgery, leading to significant morbidity, mortality, and increased healthcare costs. Despite improvements in surgical methods and perioperative care, the challenge of AL persists.

Objectives: Explore the impact of body mass index (BMI) on the risk of AL following curative treatment for rectal cancer, providing insight into its predictive value.

Design: Retrospective review.

Settings: Data were collected from a single tertiary center, emphasizing the specialized postoperative outcomes in a high-care setting.

Patients and methods: The study population was comprised patients who underwent sphincter-saving surgery combined with neoadjuvant chemoradiation for rectal cancer from 2001 to 2011. Patients with anastomotic stenosis were excluded.

Main outcome measures: The primary outcome investigated was the occurrence of AL post-surgery. Secondary outcomes included the assessment of local cancer recurrence rates within the AL group.

Sample size: 224; 13 excluded.

Results: Of 237 patients who underwent surgery, 13 with anastomotic stenosis were excluded from this study. Of the remaining 224, 15 individuals (6.3%) developed AL. A potential association between higher BMI and increased AL risk was identified. Additionally, the study noted a higher incidence of local rectal cancer recurrence in the group that developed leakage.

Conclusion: The findings suggest BMI as a significant predictive factor for AL after curative rectal cancer treatment. This emphasizes the need for heightened awareness and possible preoperative counseling for obese patients regarding their increased risk of postoperative leakage.

Limitations: The study was retrospective with all the inherit biases of such studies. The sample size was small and this may have introduced a type 2 statistical error.

背景:吻合口漏(AL)是直肠手术后的一种严重并发症,可导致严重的发病率、死亡率和医疗费用的增加。尽管手术方法和围手术期护理有所改进,但 AL 的挑战依然存在:探讨体重指数(BMI)对直肠癌根治性治疗后AL风险的影响,深入了解其预测价值:设计:回顾性研究:数据收集自一家三级医疗中心,强调高护理环境下的专业术后结果:研究对象包括2001年至2011年期间接受括约肌挽救手术联合新辅助化疗治疗直肠癌的患者。不包括吻合口狭窄的患者:主要研究结果:主要研究结果是术后AL的发生率。次要结果包括评估AL组的局部癌症复发率。样本量:224;排除13例:结果:在接受手术的 237 名患者中,有 13 名吻合口狭窄患者被排除在本研究之外。在剩余的 224 名患者中,有 15 人(6.3%)出现了 AL。研究发现,体重指数越高,发生 AL 的风险越高。此外,该研究还注意到,在发生渗漏的人群中,局部直肠癌复发率较高:结论:研究结果表明,体重指数是直肠癌根治性治疗后发生 AL 的重要预测因素。结论:研究结果表明,BMI 是直肠癌根治术后发生 AL 的重要预测因素,这强调了有必要提高肥胖患者对术后渗漏风险增加的认识,并为其提供可能的术前咨询:本研究为回顾性研究,具有此类研究固有的偏倚性。样本量较小,这可能会导致2型统计误差。
{"title":"Role of body mass index in anastomotic leakage after curative treatment for rectal cancer.","authors":"Reem Alharbi, Osama Almosallam, Sara Albastaki, Asim Almughamsi, Nasser Alsanea","doi":"10.5144/0256-4947.2024.135","DOIUrl":"10.5144/0256-4947.2024.135","url":null,"abstract":"<p><strong>Background: </strong>Anastomotic leakage (AL) represents a severe complication after rectal surgery, leading to significant morbidity, mortality, and increased healthcare costs. Despite improvements in surgical methods and perioperative care, the challenge of AL persists.</p><p><strong>Objectives: </strong>Explore the impact of body mass index (BMI) on the risk of AL following curative treatment for rectal cancer, providing insight into its predictive value.</p><p><strong>Design: </strong>Retrospective review.</p><p><strong>Settings: </strong>Data were collected from a single tertiary center, emphasizing the specialized postoperative outcomes in a high-care setting.</p><p><strong>Patients and methods: </strong>The study population was comprised patients who underwent sphincter-saving surgery combined with neoadjuvant chemoradiation for rectal cancer from 2001 to 2011. Patients with anastomotic stenosis were excluded.</p><p><strong>Main outcome measures: </strong>The primary outcome investigated was the occurrence of AL post-surgery. Secondary outcomes included the assessment of local cancer recurrence rates within the AL group.</p><p><strong>Sample size: </strong>224; 13 excluded.</p><p><strong>Results: </strong>Of 237 patients who underwent surgery, 13 with anastomotic stenosis were excluded from this study. Of the remaining 224, 15 individuals (6.3%) developed AL. A potential association between higher BMI and increased AL risk was identified. Additionally, the study noted a higher incidence of local rectal cancer recurrence in the group that developed leakage.</p><p><strong>Conclusion: </strong>The findings suggest BMI as a significant predictive factor for AL after curative rectal cancer treatment. This emphasizes the need for heightened awareness and possible preoperative counseling for obese patients regarding their increased risk of postoperative leakage.</p><p><strong>Limitations: </strong>The study was retrospective with all the inherit biases of such studies. The sample size was small and this may have introduced a type 2 statistical error.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"135-140"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do single-session Epley maneuvers treat benign paroxysmal positional vertigo? 单次埃普利手法能治疗良性阵发性位置性眩晕吗?
Pub Date : 2024-05-01 Epub Date: 2024-06-06 DOI: 10.5144/0256-4947.2024.161
Elif Kaya Çelik, Fatih Öner, Hatice Güzelküçük Akay

Background: Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular condition characterized by short-term vertigo attacks that significantly affect quality of life.

Objectives: Examine how well a single Epley maneuver worked in an outpatient setting for people with posterior canal benign paroxysmal positional vertigo (PC-BPPV) and whether they needed a second Dix-Hallpike maneuver.

Design: Prospective.

Settings: Otorhinolaryngology department of a tertiary care center.

Patients and methods: Sociodemographic data, body mass index (BMI), and systemic disease history of 75 patients diagnosed with PC-BPPV were recorded, and their relationship with success rates after the modified Epley maneuver was analyzed.

Main outcome measures: Detect cases that could not be repositioned with the diagnostic control Dix-Hallpike test performed 20 minutes after the modified Epley reposition maneuver in the same session in PC-BPPV patients.

Sample size: 75.

Results: Of the 75 patients, 31 were male (41.3%), 44 female (58.6%) with a mean (standard deviation) age of 58.6 (15.9) years age, 54.6% had one or more chronic diseases. BMI was 30 mg/kg2 and above in 31 patients (41.3%). The modified Epley maneuver was successful in 77.3%. No significant relationship was found between additional diseases or BMI in the patient group in whom the maneuver was unsuccessful.

Conclusion: The success rates of repositioning maneuvers in treating patients diagnosed with PC-BPPV are high. However, more than a single maneuver is required in some resistant patients. Second diagnostic and repositioning maneuvers performed in the same session will reduce multiple hospital admissions. While it is helpful to repeat the maneuver in the patient group where it was unsuccessful, other factors causing the failure should be investigated.

Limitations: Lack of follow-up results of patients after 7-10 days.

背景:良性阵发性位置性眩晕(BPPV良性阵发性位置性眩晕(BPPV)是最常见的外周性前庭疾病,其特点是短期眩晕发作,严重影响生活质量:目的:研究在门诊环境中对后管良性阵发性位置性眩晕(PC-BPPV)患者进行一次 Epley 手法的效果如何,以及他们是否需要进行第二次 Dix-Hallpike 手法:设计:前瞻性:患者和方法:社会人口学数据、体质指数、颅内压和颅骨重量:记录75名确诊为PC-BPPV患者的社会人口学数据、体重指数(BMI)和全身疾病史,分析其与改良Epley手法后成功率的关系:在 PC-BPPV 患者的同一疗程中,在改良 Epley 手法复位 20 分钟后进行诊断性对照 Dix-Hallpike 试验,检测无法复位的病例:75名患者中,男性31人(41.3%),女性44人(58.6%),平均(标准差)年龄为58.6(15.9)岁,54.6%的患者患有一种或多种慢性疾病。31 名患者(41.3%)的体重指数在 30 mg/kg2 及以上。77.3% 的患者成功实施了改良埃普利手法。在手法不成功的患者组中,未发现其他疾病或体重指数之间有明显关系:结论:复位手法治疗 PC-BPPV 患者的成功率很高。结论:治疗 PC-BPPV 患者的手法复位成功率很高。在同一疗程中进行第二次诊断和复位操作可减少多次入院。虽然在操作失败的患者组中重复操作是有帮助的,但应调查导致操作失败的其他因素:缺乏对 7-10 天后患者的随访结果。
{"title":"Do single-session Epley maneuvers treat benign paroxysmal positional vertigo?","authors":"Elif Kaya Çelik, Fatih Öner, Hatice Güzelküçük Akay","doi":"10.5144/0256-4947.2024.161","DOIUrl":"10.5144/0256-4947.2024.161","url":null,"abstract":"<p><strong>Background: </strong>Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular condition characterized by short-term vertigo attacks that significantly affect quality of life.</p><p><strong>Objectives: </strong>Examine how well a single Epley maneuver worked in an outpatient setting for people with posterior canal benign paroxysmal positional vertigo (PC-BPPV) and whether they needed a second Dix-Hallpike maneuver.</p><p><strong>Design: </strong>Prospective.</p><p><strong>Settings: </strong>Otorhinolaryngology department of a tertiary care center.</p><p><strong>Patients and methods: </strong>Sociodemographic data, body mass index (BMI), and systemic disease history of 75 patients diagnosed with PC-BPPV were recorded, and their relationship with success rates after the modified Epley maneuver was analyzed.</p><p><strong>Main outcome measures: </strong>Detect cases that could not be repositioned with the diagnostic control Dix-Hallpike test performed 20 minutes after the modified Epley reposition maneuver in the same session in PC-BPPV patients.</p><p><strong>Sample size: </strong>75.</p><p><strong>Results: </strong>Of the 75 patients, 31 were male (41.3%), 44 female (58.6%) with a mean (standard deviation) age of 58.6 (15.9) years age, 54.6% had one or more chronic diseases. BMI was 30 mg/kg<sup>2</sup> and above in 31 patients (41.3%). The modified Epley maneuver was successful in 77.3%. No significant relationship was found between additional diseases or BMI in the patient group in whom the maneuver was unsuccessful.</p><p><strong>Conclusion: </strong>The success rates of repositioning maneuvers in treating patients diagnosed with PC-BPPV are high. However, more than a single maneuver is required in some resistant patients. Second diagnostic and repositioning maneuvers performed in the same session will reduce multiple hospital admissions. While it is helpful to repeat the maneuver in the patient group where it was unsuccessful, other factors causing the failure should be investigated.</p><p><strong>Limitations: </strong>Lack of follow-up results of patients after 7-10 days.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"161-166"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of conservative and surgical approaches in tubal ectopic pregnancy on fertility. 输卵管异位妊娠的保守治疗和手术治疗对生育的影响。
Pub Date : 2024-05-01 Epub Date: 2024-06-06 DOI: 10.5144/0256-4947.2024.141
Riza Dur, Aysel Nalcakan, Okan Aytekin, Derya Akdag Cirik, Basak Yaniktepe, Orhan Gelisen

Background: Medical treatment, expectant approaches, and surgical treatment options are available in the treatment of ectopic pregnancy. Regardless of the treatment, in addition to its effectiveness, the main concern is to limit the risk of relapse and preserve fertility.

Objectives: Determine the impact of medical or surgical treatment for ectopic pregnancy on future fertility.

Design: Retrospective.

Setting: Department of obstrtrics and gynecolgy at Ankara Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.

Patients and methods: Patients who were treated for ectopic pregnancy between June 2016 and November 2019 were allocated into two groups. Expectant approach or medical treatment by methotrexate constituted the conservative treatment group while salpingectomy by laparoscopy indicated the surgical treatment group.

Main outcome measures: Fertility rates within two years following treatment were evaluated according to treatment options.

Sample size: 202 patients.

Results: Of the 202 patients, 128 had medical treatment and 74 patients had surgical treatment for ectopic pregnancy. Of 272 diagnosed with ectopic pregnancy, 70 were excluded for various reasons. Parity and unemployment rate was significantly higher in the surgical treatment (P=.006 and P=.12, respectively). Moreover, ectopic mass size and serum β-hCG levels were significantly higher in the surgical treatment group (P<.001 and P<.001, respectively). There were no significant differences between the conservative and surgical treatment groups in time to pregnancy (17.0 months vs 19.0 months, P=.255). Similarly, there was no significant difference between the conservative and surgical treatment groups with respect to history of infertility (P=.12). There were no significant differences between the conservative and surgical treatment groups in terms of live birth (51.6% vs 44.6%) and ectopic pregnancy (2.3% vs 1.4%) (P=.72 for both). There was no significant difference between the conservative and surgical treatment groups with respect to infertility rate (35.9% vs 41.9%, P=.72) and admittance to the IVF program (3.9% vs 6.8%, P=.39) following ectopic pregnancy treatment.

Conclusions: Reproductive outcomes did not differ significantly in women undergoing expectant management, medical treatment, and surgery for ectopic pregnancy. This finding suggests that clinicians should not hesitate to act in favor of surgical treatment for ectopic pregnancy even if there were concerns for future fertility.

Limitations: Retrospective study.

背景:治疗宫外孕的方法有药物治疗、期待疗法和手术治疗。无论哪种治疗方法,除了疗效外,最主要的是限制复发风险和保留生育能力:确定宫外孕药物或手术治疗对未来生育能力的影响:设计:回顾性:地点:土耳其安卡拉 Etlik Zübeyde Hanım 妇女健康培训与研究医院妇产科:将2016年6月至2019年11月期间接受宫外孕治疗的患者分为两组。保守治疗组采用期待疗法或甲氨蝶呤药物治疗,手术治疗组采用腹腔镜输卵管切除术:根据治疗方案评估治疗后两年内的生育率:结果:在202名患者中,128名患者接受了药物治疗,74名患者接受了手术治疗。在 272 名确诊为宫外孕的患者中,有 70 人因各种原因被排除在外。手术治疗患者的胎次和失业率明显更高(分别为 P=.006 和 P=.12)。此外,手术治疗组的异位妊娠块大小和血清β-hCG水平也明显高于手术治疗组(PPP=.255)。同样,保守治疗组和手术治疗组在不孕史方面也无明显差异(P=.12)。保守治疗组和手术治疗组在活产率(51.6% 对 44.6%)和宫外孕率(2.3% 对 1.4%)方面没有明显差异(均为 P=.72)。保守治疗组和手术治疗组在宫外孕治疗后的不孕率(35.9% vs 41.9%,P=.72)和接受试管婴儿计划(3.9% vs 6.8%,P=.39)方面没有明显差异:结论:接受预产期管理、药物治疗和手术治疗宫外孕的妇女的生殖结果没有明显差异。这一结果表明,即使担心未来的生育能力,临床医生也应毫不犹豫地选择手术治疗宫外孕:局限性:回顾性研究。
{"title":"The effects of conservative and surgical approaches in tubal ectopic pregnancy on fertility.","authors":"Riza Dur, Aysel Nalcakan, Okan Aytekin, Derya Akdag Cirik, Basak Yaniktepe, Orhan Gelisen","doi":"10.5144/0256-4947.2024.141","DOIUrl":"10.5144/0256-4947.2024.141","url":null,"abstract":"<p><strong>Background: </strong>Medical treatment, expectant approaches, and surgical treatment options are available in the treatment of ectopic pregnancy. Regardless of the treatment, in addition to its effectiveness, the main concern is to limit the risk of relapse and preserve fertility.</p><p><strong>Objectives: </strong>Determine the impact of medical or surgical treatment for ectopic pregnancy on future fertility.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Setting: </strong>Department of obstrtrics and gynecolgy at Ankara Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.</p><p><strong>Patients and methods: </strong>Patients who were treated for ectopic pregnancy between June 2016 and November 2019 were allocated into two groups. Expectant approach or medical treatment by methotrexate constituted the conservative treatment group while salpingectomy by laparoscopy indicated the surgical treatment group.</p><p><strong>Main outcome measures: </strong>Fertility rates within two years following treatment were evaluated according to treatment options.</p><p><strong>Sample size: </strong>202 patients.</p><p><strong>Results: </strong>Of the 202 patients, 128 had medical treatment and 74 patients had surgical treatment for ectopic pregnancy. Of 272 diagnosed with ectopic pregnancy, 70 were excluded for various reasons. Parity and unemployment rate was significantly higher in the surgical treatment (<i>P</i>=.006 and <i>P</i>=.12, respectively). Moreover, ectopic mass size and serum β-hCG levels were significantly higher in the surgical treatment group (<i>P</i><.001 and <i>P</i><.001, respectively). There were no significant differences between the conservative and surgical treatment groups in time to pregnancy (17.0 months vs 19.0 months, <i>P</i>=.255). Similarly, there was no significant difference between the conservative and surgical treatment groups with respect to history of infertility (<i>P</i>=.12). There were no significant differences between the conservative and surgical treatment groups in terms of live birth (51.6% vs 44.6%) and ectopic pregnancy (2.3% vs 1.4%) (<i>P</i>=.72 for both). There was no significant difference between the conservative and surgical treatment groups with respect to infertility rate (35.9% vs 41.9%, <i>P</i>=.72) and admittance to the IVF program (3.9% vs 6.8%, <i>P</i>=.39) following ectopic pregnancy treatment.</p><p><strong>Conclusions: </strong>Reproductive outcomes did not differ significantly in women undergoing expectant management, medical treatment, and surgery for ectopic pregnancy. This finding suggests that clinicians should not hesitate to act in favor of surgical treatment for ectopic pregnancy even if there were concerns for future fertility.</p><p><strong>Limitations: </strong>Retrospective study.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"141-145"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre. 采用断层疗法治疗局部晚期鼻咽癌的青少年:费萨尔国王专科医院和研究中心的经验。
Pub Date : 2024-05-01 Epub Date: 2024-06-06 DOI: 10.5144/0256-4947.2024.153
Abdulrahman Aldakheel, Mohammed Aldehaim, Mohammed Saleh Alwhaid, Renda Alhabib, Muhammad Suhail Anwar, Balqees Alzayed, Khurram Shehzad, Hazem Ghebeh, Nasser Al-Rajhi

Background: Nasopharyngeal carcinoma (NPC) is a rare disease worldwide; To the best of our knowledge, there is no established standard of care specifically tailored for the adolescent population. The majority of existing research relies on retrospective data analysis.

Objective: Evaluate clinical features, treatment results, prognostic factors and late toxicities of locally advanced NPC patients treated with tomotherapy.

Design: Retrospective.

Settings: Tertiary care hospital.

Patients and methods: Between January 2007 and January 2020, we treated patients with NPC, aged between 14 and 21 years, with concomitant chemoradiotherapy using tomotherapy at our institution. We prospectively collected details of clinical characteristics, treatment modalities, outcomes and prognostic factors of these patients and then analysed them retrospectively.

Main outcome measures: 3-5 years overall survival (OS), 3-5 years locoregional control rate, 3-5 years disease-free survival (DFS), prognostic factors.

Sample size: 51 patients.

Results: There were 26 male and 25 female patients included in our study. The mean age was 16.5 years, 5 (9.8%) patients with stage III, and 46 (90.2%) with stage IVa according to the American Joint Committee on Cancer, 8th edition staging system. Most patients (98%) received two or more cycles of induction chemotherapy. All patients received concomitant chemoradiotherapy. The median total dose of radiotherapy delivered was 6600 cGy (range 4800-7000). With a median follow-up of 73 months (range 9-168 months), a 5-year locoregional control rate, 5-year OS and 5-year DFS rates were 100%, 86.8% and 71.7%, respectively. Five years later, disease control was 71.7%. Ten (19.6%) patients had disease recurrence in the form of distant metastases during the follow up.

Conclusions: Helical tomotherapy has an excellent late toxicity profile without compromising clinical outcome for patients with NPC. Radiotherapy remains the mainstay of treatment of nasopharyngeal carcinoma to achieve remarkable local control rates.

Limitations: Single institution experience, small number of patients, and retrospective design.

背景:鼻咽癌(NPC)是一种世界罕见的疾病;据我们所知,目前还没有专门针对青少年人群的既定治疗标准。现有研究大多依赖于回顾性数据分析:评估采用断层疗法治疗的局部晚期鼻咽癌患者的临床特征、治疗效果、预后因素和后期毒性反应:设计:回顾性:患者和方法:2007年1月至2020年1月:2007年1月至2020年1月期间,我们在本院治疗了年龄在14至21岁之间的鼻咽癌患者,并同时使用了断层放疗进行化疗。我们前瞻性地收集了这些患者的临床特征、治疗方式、疗效和预后因素,然后进行了回顾性分析:3-5年总生存率(OS)、3-5年局部控制率、3-5年无病生存率(DFS)、预后因素:结果:本研究共纳入 26 名男性患者和 25 名女性患者。平均年龄为 16.5 岁,根据美国癌症联合委员会第八版分期系统,5 名患者(9.8%)为 III 期,46 名患者(90.2%)为 IVa 期。大多数患者(98%)接受了两个或两个以上周期的诱导化疗。所有患者都同时接受了放化疗。放疗的中位总剂量为6600 cGy(范围为4800-7000)。中位随访时间为73个月(9-168个月),5年局部控制率、5年OS率和5年DFS率分别为100%、86.8%和71.7%。五年后,疾病控制率为 71.7%。10例(19.6%)患者在随访期间以远处转移的形式复发:结论:对于鼻咽癌患者来说,螺旋断层疗法具有良好的后期毒性,且不会影响临床疗效。放疗仍是鼻咽癌治疗的主要手段,可实现显著的局部控制率:局限性:单机构经验、患者人数少、回顾性设计。
{"title":"Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre.","authors":"Abdulrahman Aldakheel, Mohammed Aldehaim, Mohammed Saleh Alwhaid, Renda Alhabib, Muhammad Suhail Anwar, Balqees Alzayed, Khurram Shehzad, Hazem Ghebeh, Nasser Al-Rajhi","doi":"10.5144/0256-4947.2024.153","DOIUrl":"10.5144/0256-4947.2024.153","url":null,"abstract":"<p><strong>Background: </strong>Nasopharyngeal carcinoma (NPC) is a rare disease worldwide; To the best of our knowledge, there is no established standard of care specifically tailored for the adolescent population. The majority of existing research relies on retrospective data analysis.</p><p><strong>Objective: </strong>Evaluate clinical features, treatment results, prognostic factors and late toxicities of locally advanced NPC patients treated with tomotherapy.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Settings: </strong>Tertiary care hospital.</p><p><strong>Patients and methods: </strong>Between January 2007 and January 2020, we treated patients with NPC, aged between 14 and 21 years, with concomitant chemoradiotherapy using tomotherapy at our institution. We prospectively collected details of clinical characteristics, treatment modalities, outcomes and prognostic factors of these patients and then analysed them retrospectively.</p><p><strong>Main outcome measures: </strong>3-5 years overall survival (OS), 3-5 years locoregional control rate, 3-5 years disease-free survival (DFS), prognostic factors.</p><p><strong>Sample size: </strong>51 patients.</p><p><strong>Results: </strong>There were 26 male and 25 female patients included in our study. The mean age was 16.5 years, 5 (9.8%) patients with stage III, and 46 (90.2%) with stage IVa according to the American Joint Committee on Cancer, 8th edition staging system. Most patients (98%) received two or more cycles of induction chemotherapy. All patients received concomitant chemoradiotherapy. The median total dose of radiotherapy delivered was 6600 cGy (range 4800-7000). With a median follow-up of 73 months (range 9-168 months), a 5-year locoregional control rate, 5-year OS and 5-year DFS rates were 100%, 86.8% and 71.7%, respectively. Five years later, disease control was 71.7%. Ten (19.6%) patients had disease recurrence in the form of distant metastases during the follow up.</p><p><strong>Conclusions: </strong>Helical tomotherapy has an excellent late toxicity profile without compromising clinical outcome for patients with NPC. Radiotherapy remains the mainstay of treatment of nasopharyngeal carcinoma to achieve remarkable local control rates.</p><p><strong>Limitations: </strong>Single institution experience, small number of patients, and retrospective design.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"153-160"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of TLR4 gene rs4986790 and rs4986791 polymorphisms with asthma susceptibility: meta-analysis and trial sequential analysis. TLR4基因rs4986790和rs4986791多态性与哮喘易感性的关系:荟萃分析和试验序列分析。
Pub Date : 2024-05-01 Epub Date: 2024-06-06 DOI: 10.5144/0256-4947.2024.183
Nan Guo, Haokun Tian, Tiangang Song, Yu Peng

Background: The current understanding of the correlation between TLR4 gene (toll-like receptor 4) rs4986790 and rs4986791 polymorphisms and asthma susceptibility is inconclusive, with studies and populations yielding conflicting results.

Objectives: Evaluate this relationship using meta-analysis and trial sequential analysis (TSA).

Patients and methods: Databases were systematically queried for relevant articles from the establishment of the database to 19 June 2023 adhering to predefined inclusion and exclusion criteria. Two authors independently conducted screening, data extraction, and quality evaluation. Meta-analysis and TSA were carried out using RevMan 5.4, StataMP 17.0, and TSA 0.9.5.10 Beta, with α=0.05. Subgroup analyses were conducted based on racial demographics. A sensitivity analysis was conducted employing a one-by-one exclusion method. Publication bias was assessed using the Begg and Egger tests.

Main outcome measures: Association of asthma susceptibility with TLR4 gene rs4986790 and rs4986791 polymorphisms.

Sample size: 23 articles included 22 studies on the rs4986790 polymorphism and 11 studies on the rs4986791 polymorphism on the TLR4 gene.

Results: Out of 692 studies screened, 23 met the inclusion criteria. While the overall meta-analysis showed no significant association between the TLR4 rs4986790 polymorphism and asthma susceptibility, subgroup analysis revealed a significant link in the Caucasian population. A significant association was noted in the meta-analysis, particularly among Asian populations, on the rs4986791 polymorphism. The sensitivity analysis indicated that the meta-analysis results were relatively stable. Publication bias analysis revealed minimal influence from publication bias. However, TSA was underscored by the necessity for additional original studies to further validate specific outcomes.

Conclusions: Our study underscores the ethnicity-specific impact on the relationship between TLR4 polymorphisms and asthma susceptibility. While the overall findings for rs4986790 were not significant, the association with the Caucasian population merits further investigation. Furthermore, rs4986791 demonstrated a significant correlation with asthma susceptibility, specifically among Asian populations.

Limitations: Our study predominantly examined the rs4986790 and rs4986791 polymorphisms, overlooking the potential influence of other genetic variants within TLR4.

背景:目前对 TLR4 基因(toll 样受体 4)rs4986790 和 rs4986791 多态性与哮喘易感性之间相关性的理解尚无定论,研究和人群得出的结果相互矛盾:利用荟萃分析和试验序列分析(TSA)评估这种关系:按照预定义的纳入和排除标准,系统查询数据库中从数据库建立到 2023 年 6 月 19 日的相关文章。两位作者独立进行筛选、数据提取和质量评估。元分析和TSA使用RevMan 5.4、StataMP 17.0和TSA 0.9.5.10 Beta进行,α=0.05。根据种族人口统计学进行了分组分析。采用逐一排除法进行了敏感性分析。采用 Begg 和 Egger 检验对发表偏倚进行了评估:哮喘易感性与 TLR4 基因 rs4986790 和 rs4986791 多态性的关系。样本量:23 篇文章,包括 22 项关于 TLR4 基因 rs4986790 多态性的研究和 11 项关于 TLR4 基因 rs4986791 多态性的研究:在筛选出的 692 项研究中,有 23 项符合纳入标准。虽然总体荟萃分析表明 TLR4 rs4986790 多态性与哮喘易感性之间没有显著关联,但亚组分析显示在白种人群中存在显著关联。在荟萃分析中发现,rs4986791 多态性与哮喘易感性有明显关联,尤其是在亚洲人群中。敏感性分析表明,荟萃分析结果相对稳定。发表偏倚分析显示,发表偏倚的影响微乎其微。然而,TSA强调需要更多的原创性研究来进一步验证特定结果:我们的研究强调了种族特异性对 TLR4 多态性与哮喘易感性之间关系的影响。虽然 rs4986790 的总体结果并不显著,但与白种人群的关联值得进一步研究。此外,rs4986791 与哮喘易感性有显著相关性,特别是在亚洲人群中:我们的研究主要考察了 rs4986790 和 rs4986791 多态性,忽略了 TLR4 中其他遗传变异的潜在影响。
{"title":"Association of TLR4 gene rs4986790 and rs4986791 polymorphisms with asthma susceptibility: meta-analysis and trial sequential analysis.","authors":"Nan Guo, Haokun Tian, Tiangang Song, Yu Peng","doi":"10.5144/0256-4947.2024.183","DOIUrl":"10.5144/0256-4947.2024.183","url":null,"abstract":"<p><strong>Background: </strong>The current understanding of the correlation between TLR4 gene (toll-like receptor 4) rs4986790 and rs4986791 polymorphisms and asthma susceptibility is inconclusive, with studies and populations yielding conflicting results.</p><p><strong>Objectives: </strong>Evaluate this relationship using meta-analysis and trial sequential analysis (TSA).</p><p><strong>Patients and methods: </strong>Databases were systematically queried for relevant articles from the establishment of the database to 19 June 2023 adhering to predefined inclusion and exclusion criteria. Two authors independently conducted screening, data extraction, and quality evaluation. Meta-analysis and TSA were carried out using RevMan 5.4, StataMP 17.0, and TSA 0.9.5.10 Beta, with α=0.05. Subgroup analyses were conducted based on racial demographics. A sensitivity analysis was conducted employing a one-by-one exclusion method. Publication bias was assessed using the Begg and Egger tests.</p><p><strong>Main outcome measures: </strong>Association of asthma susceptibility with TLR4 gene rs4986790 and rs4986791 polymorphisms.</p><p><strong>Sample size: </strong>23 articles included 22 studies on the rs4986790 polymorphism and 11 studies on the rs4986791 polymorphism on the TLR4 gene.</p><p><strong>Results: </strong>Out of 692 studies screened, 23 met the inclusion criteria. While the overall meta-analysis showed no significant association between the TLR4 rs4986790 polymorphism and asthma susceptibility, subgroup analysis revealed a significant link in the Caucasian population. A significant association was noted in the meta-analysis, particularly among Asian populations, on the rs4986791 polymorphism. The sensitivity analysis indicated that the meta-analysis results were relatively stable. Publication bias analysis revealed minimal influence from publication bias. However, TSA was underscored by the necessity for additional original studies to further validate specific outcomes.</p><p><strong>Conclusions: </strong>Our study underscores the ethnicity-specific impact on the relationship between TLR4 polymorphisms and asthma susceptibility. While the overall findings for rs4986790 were not significant, the association with the Caucasian population merits further investigation. Furthermore, rs4986791 demonstrated a significant correlation with asthma susceptibility, specifically among Asian populations.</p><p><strong>Limitations: </strong>Our study predominantly examined the rs4986790 and rs4986791 polymorphisms, overlooking the potential influence of other genetic variants within TLR4.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"183-194"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Saudi medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1